Protagonist Therapeutics Inc (PTGX)
46.76
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
46.80
+0.04
(+0.09%)
After-Hours: 20:00
Protagonist Therapeutics Profit Margin (Quarterly): -734.7% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -734.7% |
March 31, 2024 | 81.32% |
December 31, 2023 | 45.56% |
September 30, 2023 | |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | -4.78K% |
March 31, 2022 | -81.37% |
December 31, 2021 | -428.3% |
September 30, 2021 | -328.6% |
June 30, 2021 | -1.36K% |
March 31, 2021 | -387.8% |
Date | Value |
---|---|
December 31, 2020 | -334.3% |
September 30, 2020 | -59.20% |
June 30, 2020 | -312.4% |
March 31, 2020 | -550.6% |
December 31, 2019 | -643.7% |
September 30, 2019 | -396.3% |
June 30, 2019 | |
March 31, 2019 | -904.0% |
December 31, 2018 | -589.2% |
September 30, 2018 | -142.8% |
June 30, 2018 | -74.21% |
March 31, 2018 | -71.06% |
December 31, 2017 | -27.05% |
September 30, 2017 | -54.95% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.78K%
Minimum
Jun 2022
81.32%
Maximum
Mar 2024
-705.2%
Average
-361.0%
Median
Profit Margin (Quarterly) Benchmarks
Johnson & Johnson | 11.99% |
Assembly Biosciences Inc | -130.7% |
Precision BioSciences Inc | 65.63% |
Entrada Therapeutics Inc | 58.11% |
NovaBay Pharmaceuticals Inc | -66.04% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 41.76% |
Return on Assets | 37.73% |
Return on Invested Capital | 41.76% |
Operating Margin (Quarterly) | -931.0% |
Return on Net Operating Assets | 239.1% |